SLC2A1 and cancer: Abnormally stimulated HIF-1 functioning as a transcription factor inhibits mitochondrial activity and promotes glycolysis and cancer cell growth by facilitating the expression of glycolysis transporters and key enzymes such as GLUT1, HK2, FBP, PKM2, and LDHA (187–189).